Harvard Bioscience (HBIO) Non Operating Income (2010 - 2026)
Harvard Bioscience (HBIO) reported Non Operating Income of -$405000.0 for Q1 2026, up 64.03% year-over-year from -$246903.1 in Q1 2025, and down 109.88% quarter-over-quarter from $4.1 million in Q4 2025.
Harvard Bioscience (HBIO) Non Operating Income (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Non Operating Income data on file, last reported at -$405000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$405000.0, up 64.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 180.3% YoY), and the FY2025 annual result was $208000.0, up 103.81% from the prior year.
- Non Operating Income retreated to -$405000.0 in Q1 2026 per HBIO's latest filing, from $4.1 million in the prior quarter.
- Over five years, Non Operating Income peaked at $4.1 million in Q4 2025 and troughed at -$2.9 million in Q2 2023.
- A 5-year average of -$272764.7 and a median of -$332000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income slumped 5915.56% in 2024, then soared 608.12% in 2025.
- A 5-year view of Non Operating Income shows it stood at $2.1 million in 2022, then tumbled by 115.71% to -$332000.0 in 2023, then jumped by 274.4% to $579000.0 in 2024, then soared by 608.12% to $4.1 million in 2025, then plunged by 109.88% to -$405000.0 in 2026.
- Business Quant data shows HBIO's Non Operating Income at -$405000.0 in Q1 2026, $4.1 million in Q4 2025, and -$365000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 85.10 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 86.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -131.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -1.37 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -200,000.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -4.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.02 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -6.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -405,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -405,000.00 |
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | -365,000.00 |
| Jun 30, 2025 | -644,000.00 |
| Mar 31, 2025 | -1.13 Mn |
| Dec 31, 2024 | 579,000.00 |
| Sep 30, 2024 | -2.62 Mn |
| Jun 30, 2024 | -181,000.00 |
| Mar 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | -542,000.00 |
| Dec 31, 2022 | 2.11 Mn |
| Sep 30, 2022 | -179,000.00 |
| Jun 30, 2022 | -62,000.00 |
| Mar 31, 2022 | 78,000.00 |
| Dec 31, 2021 | -1.73 Mn |
| Sep 30, 2021 | -130,000.00 |
| Jun 30, 2021 | -690,000.00 |